Metoprolol Ratiopharm (Metoprolol Tartrate, Hydrochlorothiazide)

Metoprolol tartrate blocks β1‑adrenergic receptors in the heart, decreasing heart rate, contractility, and renin release, which lowers cardiac output. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urine output and reducing plasma volume. The combined actions produce an additive reduction in blood pressure.

The appropriate dose of Metoprolol Ratiopharm is individualized by the prescribing clinician based on the patient’s blood pressure, renal function, and overall health status. Dosage may be adjusted over time to achieve target blood pressure while minimizing side effects. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for Metoprolol Ratiopharm in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as the drug may be excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Metoprolol Ratiopharm. GNH India supplies hospitals, pharmacies and procurement teams worldwide. The sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Metoprolol Ratiopharm offers a dual mechanism—beta‑blockade plus diuresis—providing a synergistic blood‑pressure‑lowering effect. Compared with single‑agent therapies, the combination can achieve target pressures with fewer tablets, but it may carry a higher risk of electrolyte disturbances than agents without a diuretic component. Choice of therapy should be guided by patient comorbidities, tolerance, and physician judgment.

Metoprolol Ratiopharm tablets should be stored at ambient temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain stability throughout its shelf life.

Metoprolol Ratiopharm is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescribing clinician’s guidance on timing relative to meals to maintain consistent absorption.

Serious risks include severe hypotension, marked electrolyte imbalances (especially low potassium or sodium), acute kidney injury, significant bradycardia, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling, severe dizziness, or any signs of an allergic response.

Metoprolol Ratiopharm is contraindicated in patients with known hypersensitivity to metoprolol, hydrochlorothiazide, or any component of the formulation. It should also be avoided in individuals with severe bradycardia, advanced heart block, uncompensated heart failure, or severe renal impairment unless specifically directed by a specialist.